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Abstract
Background: Diabetes is the third most common chronic condition in childhood and poor glycaemic control
leads to serious short-term and life-limiting long-term complications. In addition to optimal medical management,
it is widely recognised that psychosocial and educational factors play a key role in improving outcomes for young
people with diabetes. Recent systematic reviews of psycho-educational interventions recognise the need for new
methods to be developed in consultation with key stakeholders including patients, their families and the
multidisciplinary diabetes healthcare team.
Methods/design: Following a development phase involving key stakeholders, a psychosocial intervention for use
by paediatric diabetes staff and not requiring input from trained psychologists has been developed, incorporating
a communication skills training programme for health professionals and a shared agenda-setting tool. The
effectiveness of the intervention will be evaluated in a cluster-randomised controlled trial (RCT). The primary
outcome, to be measured in children aged 4-15 years diagnosed with type 1 diabetes for at least one year, is the
effect on glycaemic control (HbA1c) during the year after training of the healthcare team is completed. Secondary
outcomes include quality of life for patients and carers and cost-effectiveness. Patient and carer preferences for
service delivery will also be assessed. Twenty-six paediatric diabetes teams are participating in the trial, recruiting a
total of 700 patients for evaluation of outcome measures. Half the participating teams will be randomised to
receive the intervention at the beginning of the trial and remaining centres offered the training package at the
end of the one year trial period.
Discussion: The primary aim of the trial is to determine whether a communication skills training intervention for
specialist paediatric diabetes teams will improve clinical and psychological outcomes for young people with type 1
diabetes. Previous research indicates the effectiveness of specialist psychological interventions in achieving
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Background
Diabetes is the third most common chronic disease in
childhood, with new cases affecting at least 13.5 per
100,000 children per year in the UK [1]. The incidence
has doubled in the last 20 years. To reduce the risk of
long-term complications associated with elevated blood
glucose (e.g. retinopathy, nephropathy) effective treat-
ment requires regular administration of insulin, most
commonly by two to four injections daily in conjunction
with a healthy lifestyle. The efficacy of management is
monitored in the short-term by regular self-measure-
ment of blood glucose concentrations and in the longer
term by monitoring of glycosylated haemoglobin
(HbA1c) levels in the blood and regular clinical review
in paediatric diabetes clinics.
Psychosocial aspects of diabetes
It is well recognised [2] that psychosocial and educa-
tional influences play a key role in determining manage-
ment outcomes in children with diabetes. For example,
a large audit in Scotland has shown that family structure
is associated with glycaemic control throughout child-
hood [3]. During adolescence, rapid physical change
(puberty) leads to relative resistance to the effects of
insulin [4]. Concurrent major developmental changes
include increasing independence, emerging sexuality and
increased stress from peer and academic pressures.
These factors together are often associated with dete-
riorating glycaemic control.
A recent NHS Health Technology Assessment (HTA)
systematic review of the effects of educational and psy-
chosocial interventions for adolescents with diabetes
reported that there were no results from RCTs of such
interventions in the UK [5]. However, the review did
identify a study evaluating the effects of Motivational
Interviewing (MI) on behaviour change in teenagers.
The MI approach focuses on problem solving and goal
setting to facilitate behaviour change, and emphasises
the importance of using a guiding style of communica-
tion when consulting with patients. This trial was based
on positive findings from a pilot study in children [6]
and an RCT involving adults with type 2 diabetes [7,8].
The findings from this recently completed RCT of MI
in children demonstrated persisting improvements in
HbA1c up to two years after the start of a one year MI
intervention when compared to a group receiving non-
specific counselling [9]. Other psycho-educational inter-
ventions mostly in a North American context have
produced small to medium-sized beneficial effects on a
variety of diabetes management outcomes [10]. The
HTA review concluded there is a need for well-designed
clinical trials that recognise the inter-relatedness of var-
ious aspects of diabetes management and assess out-
comes specifically targeted for change. In particular, the
review recommended that such research be developed
through a consultation process with stakeholders includ-
ing patients, their families, healthcare professionals and
health economists. Given the relative scarcity of trained
clinical psychologists in paediatric diabetes services [11],
this research project has been directed towards develop-
ing and evaluating a generic intervention that does not
require delivery by trained psychologists. This require-
ment is emphasised by a more recent review [12] which
identified a small number of UK-based studies of psy-
chosocial interventions which have nevertheless been
delivered largely by psychologists [6,9,13]. This review
also described an ongoing UK evaluation of a family-
based educational intervention in children and teenagers
with diabetes [14,15].
Behaviour change: what theory and research tell us
Theories of health behaviour change (e.g. reasoned
action theory; the health action process approach) and
the research associated with them have clarified the
need to look beyond a simple approach to compliance
and change based upon the delivery of expert informa-
tion [16]. As Marteau and Lerman [17] have put it, “Just
telling people they are at risk of developing a disease is
rarely sufficient to change behaviour”. Two variables run
through many of the models as predictors of health
behaviour change: beliefs about the value of change and
beliefs about one’s capacity to succeed (self-efficacy).
The efficacy of theory-based interventions like cognitive-
behaviour therapy have largely been attributed to their
capacity to enhance self-efficacy [18]. Using a skills-
based approach to counselling has been found to be
effective in a number of fields [18,19]. So too, brief
interventions have been found to be effective in facilitat-
ing change in a number of risky health behaviours [20].
A second line of research has focused on how the ther-
apeutic relationship hinders or promotes motivation to
change: an early effort to understand the effective ingre-
dients of MI [21] identified a correlation between con-
frontational interviewing and resistance, and between
“change talk” and behaviour change [22]. A recent meta-
analysis of MI [23] found consistent evidence for
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behavioural domains. Interest in the application of MI in
the field of diabetes among young people (predominantly
adolescents) has also emerged [6,9,12,13,24]. One of the
challenges in much of this research however, has been to
specify exactly what elements of a complex method were
used by the interventionists. It appears that some of the
principles of MI can be realised in brief healthcare con-
sultations, and that helping patients to clarify for them-
selves why and how they might change their behaviour
can be more effective than brief advice-giving [25,26].
This body of work calls attention to both the direction of
consultations about change (towards enhancing coping
skills) and the way patients are spoken to (eliciting moti-
vation and solutions from them).
Intervention development
Development of the intervention, subsequently named
the ‘Talking Diabetes’ programme, was informed by the
Medical Research Council (MRC) framework for devel-
oping and evaluating (non-pharmacological) interven-
tions [27,28]. A number of principles and conceptual
aids guided intervention development. Firstly, there was
the need to integrate talk about lifestyle change, self-
control and quality of life with routine healthcare, where
patients are at the receiving end of a range of medical
and nursing interventions. Health-care staff need to find
ways of moving between providing medical care on the
one hand, and “letting go responsibility” on the other
[8], to encourage children and teenagers to take control
of their health, with assistance from others. During the
intervention development stage, a consultative stake-
holder reference group considered a consultation model
which described the value of moving flexibly between
directing, following and guiding communication styles
when talking about behaviour change. A second concep-
tual and clinical challenge was the need to move beyond
thinking about change as involving an isolated, single
behaviour, a limitation in much of the theory of beha-
viour change in health psychology. The challenge was to
help patients find a balance between multiple and inter-
related health behaviours and lifestyle choices [5,7,8,29].
Thirdly, targeting or matching interventions to the
needs of patients was a design consideration: efforts to
match interventions with patients in other fields [30,31]
have proved difficult. One approach to targeting was to
regard this as something that happens not across inter-
ventions but within the consultation, as the practitioner
shifts style and topic according to the needs of the
patient [32]. To this end, there was some evidence for
the acceptability and feasibility of using a targeting
approach based on a flexible menu of strategies in
which the practitioner and patient select a topic accord-
ing to need [31,33]. This intervention framework has
been developed from efforts to train healthcare practi-
tioners to use elements of MI, and a recent application
in drug misuse in young people has produced promising
results [34]. In the present context however, it was not
the intervention approach (MI) or content that was con-
sidered useful, but the use of a framework for targeting
within the consultation based on a menu of topics for
discussion.
Empirical and consultative work during the interven-
tion development phase helped formulate and operatio-
nalise the ‘Talking Diabetes’ intervention. These
activities included: (1) a review of psychosocial and edu-
cational interventions for children and teenagers with
diabetes; (2) a telephone survey of practitioners (doctors,
nurses, dieticians) working in UK paediatric diabetes
clinics conducted to explore existing psychosocial prac-
tice; (3) a postal survey of UK practitioners exploring
experiences and preferences for training in health com-
munication skills [35]; (4) focus groups with young peo-
ple with diabetes and with their carers; (5) observational
work of consultations within three paediatric diabetes
clinics in Wales and England; (6) experimental role-play
with practitioners and young people; (7) an ongoing sta-
keholder consultation process built around three one-
day workshops attended by teenagers with diabetes,
their parents and multi-disciplinary health-care profes-
sionals with experience of managing children with dia-
betes, and (8) local piloting of approaches with young
patients. The finalised intervention consists of a blended
learning programme for practitioners in the paediatric
diabetes field. The programme provides training in a
number of communication strategies and skills to help
practitioners prepare patients for behaviour change con-
versations and for conducting such consultations. A key
element of this strategic approach was the development
of a patient agenda-setting device (3T: TimeToTalk).
These development activities will be reported separately.
The current trial
The development stage provided evidence that the inter-
vention is feasible for teams managing care, and is
acceptable to patients and carers. A randomised con-
trolled trial is now needed to test its effectiveness. The
primary objective of the trial is to determine whether a
multifaceted communication skills training intervention
(incorporating a shared agenda setting component) for
non-psychologist members of a paediatric diabetes team
will improve clinical outcomes (HbA1c) for young peo-
ple with type 1 diabetes. Secondary objectives include
assessing intervention impact upon psychosocial out-
comes (including quality of life), and assessing cost-
effectiveness. A process evaluation will assess skill reten-
tion, competency and confidence of clinical team mem-
bers in delivering the intervention.
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Ethical and governance approval
Multi-centre approval has been granted by Berkshire
Research Ethics Committee (07/MRE12/9). Site-specific
approval has been granted by local RECs at all trial sites
and all participating Acute Trust Research and Develop-
ment Departments.
Design
The study is a pragmatic cluster randomised controlled
trial (Figure 1). Twenty-six teams will be randomised to
receive training at the start (intervention group) or the
end of the one-year study period (control group).
Sample size
In order for an individually randomised trial to have
80% power to detect a moderate effect size of 0.4 for
HbA1c at a 5% significance level, 200 patients would be
required. Audit data from a Welsh paediatric diabetes
interest group (The Brecon Group) relating to 750 chil-
dren from all 13 centres in Wales indicates an intra-
cluster correlation coefficient of 0.08 for HbA1c in
patients aged 4 - 15 years. With 24 centres recruiting an
average of 23 patients each, this inflates the total sample
size required to 550. To allow for loss to follow-up, the
intention is to recruit 700 patients (78% follow-up).
Twenty-six centres have been recruited to allow for any
subsequent centre drop-out.
Clinic and patient selection
Potential clinics were approached using a variety of
recruitment methods. Flyers outlining the nature of the
study were distributed to members of the British Society
for Paediatric Endocrinology and Diabetes (BSPED) and
consultants and diabetes specialist nurses on a database
compiled as a result of the surveys carried out during
the development phase. Flyers were also distributed at
professional and scientific conferences. Expressions of
interest were received from 54 UK clinics. Thirty centres
were approached to participate based on clinic size and
geographical location: 26 agreed to take part and were
able to meet contractual requirements.
Patient recruitment  
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(n =13 clinics; n =350 patients) 
Routine data collection: 
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Figure 1 Trial structure and outcomes.
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sented prior to randomisation and the incentive of
receiving training at the end of the study is provided to
avoid differential levels of dropout or engagement
between the two groups of teams. Recruitment bias is
common in cluster randomised trials [36]. In this study,
patients are identified and approached by a specially
trained member of the local team (or occasionally a
UKCRN research nurse) during the period prior to team
randomisation and intervention training. All eligible
patients are identified from clinic lists by the research
nurse. A random sample of 40 patients will be selected
by the coordinating study team (from an anonymised
list) and approached en bloc by the research nurse, to
obtain a target sample of 30 recruited patients per clinic.
Inclusion and exclusion criteria
Each included clinic must be staffed by at least one pae-
diatrician with an interest in diabetes, a diabetes specia-
list nurse and comprise of 40 or more potentially
eligible children and adolescents. Eligibility criteria for
participants are provided in Table 1.
Recruitment
Participating families are recruited by the research nurse
and written informed consent obtained from a parent.
Where appropriate written informed consent or assent
is obtained from the child (N.B. both parent and patient
must be in agreement to take part in the study).
Recruitment and randomisation of clinics was underta-
ken in three blocks [37]: however, patients within each
centre will be approached en-bloc by letter.
Randomisation
Half of the trial centres will be randomised to the inter-
vention arm, and half to the control arm. Teams were
recruited and then randomisation optimally balanced
[38] for population (patient list) size. After the first bock
of randomisations, each subsequent block incorporates
the balance from the previous allocation(s).
Trial procedures
Intervention
Members of clinical teams allocated to the intervention
arm will undergo a blended training programme com-
prising web-based material and face-to-face seminars
(The Talking Diabetes Programme). The training course
aims to prepare practitioners for constructive behaviour
change conversations with patients and to provide prac-
titioners with strategies and skills for encouraging beha-
viour change. The training emphasises the importance
of shared agenda-setting, and drawing upon the Motiva-
tional Interviewing approach, emphasises the importance
of a guiding style when consulting with patients about
behaviour change. Practitioners work their way through
a number of distinct programme parts with an approxi-
mate total duration of 1.5 hours (delivered via three
main e-learning modules). In addition, more interactive
web-based components of the course allow practitioners
to record their thoughts and experiences as they pro-
ceed through the programme. Two face-to-face seminars
(approximately 2 weeks apart) with combined clinical
teams also form part of the training course. Time spent
on off-line learning activities such as discussing the
training content in pairs, is recorded online. Following
the second face-to-face workshop, participants will be
invited to submit reports of three consultations in which
they use their newly acquired skills and feedback will be
provided by pre-assigned trainers.
The training programme shows practitioners how to
u s ead e v i c e( 3 T :T i m e T o T a l k )f o rp r o m o t i n gs h a r e d
agenda-setting during clinical encounters with patients.
This consists of a rigid folder and an inserted paper
agenda pad of tear-off sheets which can be completed in
advance by patients and carers to record topics of
importance to be raised within consultations. Practi-
tioners have the option to complete a proforma on
which general topics discussed at clinic visits can be
recorded and kept with patient notes, to facilitate clini-
cal record keeping and communication between health-
care professionals. Copies of the paper agenda-setting
Table 1 Participant inclusion/exclusion criteria
Inclusion criteria Exclusion criteria
1. Type 1 diabetes 1. Not under care of parent or guardian (i.e. a looked after child)
2. 4-15 years old 2. Co-morbid chronic illness likely to impact on HbA1c independent of patient’s ability
to manage diabetes (e.g. condition requiring steroid treatment, cystic fibrosis, renal
failure)
3. Under care of paediatric/adolescent diabetes team for
duration of trial
3. In receipt of ongoing psychiatric/psychological therapy at the start of the study
4. Diabetes diagnosed > 12 months earlier 4. Other patients judged by clinical carer to be vulnerable due to existing medical or
social condition
5. Parental or carer (and child when able) consent given
6. Ability of patient and at least one parent or carer to
complete study materials (questionnaires)
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clinic to refill or replace folders as required and for
patients not otherwise recruited to the study.
Frequency & duration of follow-up
Patients are required to provide blood samples, and
patients and carers to complete questionnaires immedi-
ately post-recruitment, following their first clinic visit
during the trial phase, and at one year. Professionals
have their competencies measured post training and
after one year to assess acquisition and maintenance of
new skills. Professionals also provide attitudinal self-rat-
ing (importance and confidence) at the start and end of
the training programme and at one year.
Baseline data collection
Baseline data is collected by the research nurse either in
clinic or the patient’s home. The research nurse pro-
vides patients and carers with a copy of an age-appro-
priate questionnaire (7-10 yrs; 11-15 yrs) assessing
quality of life outcomes, to be returned directly to the
trial coordinating centre (who will also follow up non-
responders). The research nurse will complete a baseline
Case Report Form (CRF), recording demographic infor-
mation and clinical data (taken from patient notes).
Blood samples are collected by research nurses and
sent to a single UK laboratory (Diabetes Research Net-
work Wales Laboratory, Llandough Hospital) for mea-
surement of HbA1c concentrations. Results are reported
directly to the research team, following adjustment
against the Diabetes Control and Complications (DCCT)
international standard. Where a sample is lost or spoilt
in transit, the research nurse will approach the patient
and carer for consent to provide a second sample. In
t h ee v e n tt h a tap a t i e n tH b A 1 cs a m p l ei si ne x c e s so f
15.0% (considered to be indicative of a patient at signifi-
cant acute clinical risk) local diabetes teams responsible
for patient care will be informed so that comparison can
be made with the most recent HbA1c sample taken and
analysed locally. Any patient contact resulting from
notification of a high HbA1c value is at the discretion of
the patient’s diabetes care team: the research team have
no direct contact with patients in connection with
HbA1c. GPs will be informed in writing of their
patient’s participation in the trial by the research nurse.
Data collection during the trial phase: CRF and Interim
Questionnaire
Clinical patient details (HbA1c, height, weight, BMI,
insulin regimen), health service contacts and patient
borne costs are recorded by the local research nurse at
each clinic visit on the CRF. The research nurse also
records who patients consulted with, for how long, and
whether patients consulted on their own at each visit.
Patients and carers are also asked to complete an
interim questionnaire (assessing patient enablement) at
their first clinic visit following the start of the trial.
Follow-up data collection
Capillary HbA1c samples for patients, and question-
naires for patients and carers will be repeated at one
year. Where possible, primary outcome data (HbA1c)
will be collected two weeks either side of the expected
date of follow-up (i.e. within a 1-month window). Fol-
low-up questionnaires will be sent to patients and carers
directly by the trial coordinating centre. Follow-up ques-
tionnaires will also assess preferences for care using a
Discrete Choice Experiment (DCE) not previously
included at baseline.
Primary & secondary outcomes
Patient outcomes
Careful selection of outcome measures for children is
important to ensure appropriateness, feasibility and
acceptability. Measure selection has been informed by
two HTA systematic reviews [5,39] and through consul-
tation with the stakeholder reference group in the inter-
vention development phase. Patient-reported outcomes
(assessed via an age-appropriate questionnaire at base-
line and follow-up) include measures of diabetes-specific
quality of life [40-42], self-efficacy [43], patient enable-
ment [44] and patient perceptions of the diabetes team
[43,45] importance of, and confidence in their ability to
undertake diabetes care and monitoring activities
(patients aged 11+ only) and preferences for care (DCE:
follow up only [46]). Biochemical and clinical measures
for patients include HbA1c, BMI, insulin type, dose and
number of injections and self-reported frequencies of
moderate and severe hypoglycaemic episodes.
Carer outcomes
Carer outcomes include demographic information (age,
gender, ethnic origin, socio-economic status), parent
measures of quality of life, anxiety and perceptions of
the diabetes team [43] including items relating to com-
munication between practitioners, feelings towards the
next visit and continuity of care [45], importance of,
and confidence in their ability to undertake diabetes
care and monitoring activities. Proxy outcomes (patients
aged 4-11) comprise diabetes-specific quality of life [40]
and self-care [41]. Patient and carer outcome measures
are summarised in Table 2.
Resource use
The cost of the intervention includes the cost of training
intervention teams. The following training data will be
recorded: travel costs to seminars, time spent on off-line
learning activities (i.e. discussion of training content in
pairs, reported on-line), time spent at seminars and time
spent on-line (automatically recorded on website). Other
training costs (e.g. venue, training materials) will also be
calculated. Secondary costs are represented by between-
group differences in service use including in-patient
admissions (including ITU and HDU care), A&E
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betes team (home, telephone, face-to-face, electronic),
other health service contacts (GP attendances, any
other) and medication or equipment use (e.g. insulin
type and dose). Patient-borne costs are also being
assessed. These include travel to clinic, school absences
and time taken off work by carers.
Process evaluation outcomes
Training outcomes for clinical teams will be evaluated
and comprise behaviour change consultation competen-
cies assessed via audio-recording of clinical sessions
(post-training and at one year). Competencies for practi-
tioners in the control group will be assessed at the end
of the study period, prior to training [47]. Practitioners’
confidence in, and importance of incorporating beha-
viour change into consultations will also be assessed
(before and after training; one year after training); as
will any systemic service changes at follow-up (e.g. tim-
ing of consultations).
Analysis
Main analysis
The main analysis will be an intention to treat compari-
son of HbA1c values between the two groups of patients
at one year. This will use multi-level modelling to allow
for cluster (centre) and individual effects (including
baseline concentrations of HbA1c as a covariate). Sec-
ondary analysis of other outcomes such as quality of life
and cost will also be conducted using multi-level model-
ling incorporating baseline scores as covariates. A dose-
response analysis will be conducted to explore associa-
tions between the amount of patient contact and an
intervention effect. The two groups will also be com-
pared on the non-attendance rate as the intervention
may improve motivation to attend. A review of patient
outcome measures used in diabetes, whilst predomi-
nantly in adults, concluded that whilst most have been
shown to have content validity, there is less available
evidence regarding reliability and responsiveness to
change [48]. Responsiveness of the specific measures
used will be assessed using both effect sizes and correla-
tion to clinical variables and self-rated change.
Competence, confidence and importance of behaviour
change counselling will be compared between the two
groups at one year using a two level linear regression
model controlling for profession. Short and long term
impacts of the intervention will be analysed within the
intervention group only using repeated measures
ANOVA. Analysis of reliability of the competence
inventory will be conducted on the trial data.
No formal subgroup analyses are planned. However,
exploratory analysis of the impact of patient level factors
(e.g. age and gender) and clinic level factors (e.g. size of
clinic) on the effect of the intervention will be carried
out. No interim analyses are planned.
Economic evaluation
A cost effectiveness analysis is assessing total costs
against the primary outcome (HbA1c) and will be
reported in the form of an incremental cost effectiveness
ratio [49]. The economic element of the study also
involves the assessment of preferences for delivery of
care, and will be assessed using a Discrete Choice
Experiment (DCE) to be administered as a separate
questionnaire at one year only. A DCE works by pre-
senting individuals with hypothetical scenarios involving
different levels of defined attributes a n da s k i n gt h e mt o
make discrete pair-wise choices [46]. During the devel-
opment phase of the current study the patient and par-
ent focus groups and the stakeholder reference groups
were used to identify the most relevant attributes of
Table 2 Patient and carer outcome measures
Outcome Measure Respondents
Diabetes-specific quality
of life
Paediatric Quality of Life Inventory (PEDSQoL diabetes module: 11 items [40]) Patient (11+yrs), parent proxy (patients
5-11 yrs), parent
Problem Areas in Diabetes (PAID: 23 items [41])
2 global items to assess change in QoL (follow-up only)*
Perceptions of health
care provider
Health Care Climate Questionnaire (HCC: adapted from 7 to 5-point scale [43]) Patient, parent
3 additional items (respondents asked to circle an emotion to indicate
anticipatory feelings towards going to clinic)*
Patient Enablement Inventory (PEI: 6 items [44])
Continuity of Care Scale (8 items [45])
Self-efficacy Perceived Competency Scale (4 items [43]) Patient, parent
Self-care ’Mis-management’ (4 items adapted from Weisberg-Benchall et al. [42]) Patient (11+yrs), parent proxy (patients
5-11 yrs)
Importance of self-care (6 items)* and confidence in ability (6 items)* Patient, parent
*Indicates items created specifically for use in the current evaluation
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work will be described separately. In the trial phase, the
DCE will be administered to patients aged 11 and
above, and carers of all patients, at follow up. Possible
differences between children’sp r e f e r e n c e sa n dt h o s eo f
their carers will be explored.
Discussion
Psychosocial factors are well-known to have a significant
impact on the effective management of young people
with diabetes in addition to medical management.
Research which takes into account the inter-relatedness
of these aspects of successful management is therefore
required, in particular evaluations of interventions devel-
oped in consultation with key stakeholders which are
designed to target these psychosocial influences.
The primary objective of the current trial is to deter-
mine whether a training package developed in consulta-
tion with healthcare professionals, patients and carers,
for staff working in paediatric diabetes services to help
them engage their patients with behaviour change,
results in significant improvements in clinical outcome
(HbA1c) for young people with type 1 diabetes. Previous
research indicates the effectiveness of psychological
interventions in achieving sustained improvements in
glycaemic control. However, the current trial, based on
the principles of MI and behaviour change theory, is the
first to evaluate the effect on HbA1c of an intervention
in children, based on these principles but not requiring
the involvement of a trained psychologist. Clinical psy-
chology services are currently inadequate in paediatric
diabetes care: such an approach therefore allows these
limited resources to be directed where most needed,
maximising the potential feasibility of intervention deliv-
ery across the NHS. The effectiveness of the interven-
tion in terms of quality of life for patients and carers,
and cost-effectiveness will also be evaluated.
The current trial does however pose a number of
challenges, perhaps most notably relating to skill main-
tenance on behalf of the diabetes care teams. Compe-
tency assessment will therefore be carried out
immediately after training, and at the end of the one-
year trial period for intervention teams, and immediately
prior to training for control teams. Challenges common
to cluster randomised trials generally include the poten-
tial for recruitment bias. However, in the current study
all patients are identified and approached by the
research nurse during the period prior to team randomi-
sation and intervention training. Clinical teams are also
consented prior to randomisation and the incentive of
receiving training at the end of the study is provided to
avoid differential levels of drop-out or engagement
between the two groups of teams. Currently 26 centres
have been recruited to allow for some subsequent drop-
out. To allow for participant loss to follow-up, 700
patients (approximately78% follow-up) will be recruited.
T h eb r o a de n t r yc r i t e r i aa l s om e a nt h a tt h em a j o r i t yo f
each centre’s patient group will be eligible and enhances
the generalisability of the trial results.
It is expected that the current trial will add to the
growing body of evidence for the effectiveness of psy-
chosocial interventions in improving psychological and
clinical outcomes for children and teenagers with type 1
diabetes. Additional aims of the study are to demon-
strate both feasibility in terms of roll-out across the
NHS and cost-effectiveness, given that the intervention
is the first of its kind not requiring specialist input from
clinical psychology services, which are currently limited
in paediatric diabetes care.
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